SBCWW
SBC Medical Group Holdings Inc
NASDAQ · Industrials · Consulting Services · US
$0.42
+0.00%Year over year
Reported trailing growth
- Revenue
- -6.9%
- EBITDA
- +16.4%
- EBIT
- +14.1%
- EPS
- +43.6%
- Free cash flow
- +208.5%
- Operating cash flow
- +164.9%
Forward estimates
Based on analyst estimates
- Revenue
- +15.3%
- EBITDA
- -8.7%
- EPS
- +7.5%
Three-year CAGR
- Revenue
- -0.1%
- EBITDA
- +47.8%
- EBIT
- +49.7%
- Net income
- +100.6%
- EPS
- -14.1%
- Free cash flow
- -3.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026